Murine Animal Model
Experimental animal models are available for the development of new treatment. Murine animal models have particular advantages for comparative study to evaluate the efficacy and safety of different treatment modalities because many mice can be treated at the same time with easy handling. Among several experimental models, murine renal carcinoma (Renca), which arises spontaneously in Balb/c mice, is the most frequently used for the assessment of chemotherapy, immunotherapy, and radiotherapy. Renca cells readily establish tumors in isogenic mice, producing histologically proven adenocarcinoma with a predictable growth rate to mimic the clinical situation for orthotopic growth and metastasis in a reasonable time frame. Because of its poor immunogenicity and its responsiveness to immunotherapy, the number of studies using cytokine gene-modified tumor vaccines—such as interferon-alpha or interleukin-2—in the Renca system is growing. Therefore, Renca experiments greatly contribute to the analysis of the mechanisms of antitumor immune response. In this chapter, we describe several experimental systems using this Renca model.
- Single-Strand Conformation Polymorphism Mutation Analysis of the p53 Gene
- Digital Single-Nucleotide Polymorphism Analysis for Allelic Imbalance
- Genetically Modified Clostridium for Gene Therapy of Tumors
- Tumor Suppressor Genes in Lung Cancer
- SAGE as a Strategy to Isolate Cancer-Related Genes
- ERBB4 Mutation Analysis: Emerging Molecular Target for Melanoma Treatment
- Animal Models of Endotoxic Shock
- Induction of Programmed Cell Death with an Antisense Bcl-2 Oligonucleotide
- Studying Drug Resistance Using Genetically Engineered Mouse Models for Breast Cancer
- 检测RAS、MAPK、p38、p21